| Trial registration number
|
NCT05139901 |
Full text link
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05139901
|
First author
Last imported at : March 1, 2023, 9:56 a.m.
Source : ClinicalTrials.gov
|
Marko Zlicar
|
Contact
Last imported at : March 1, 2023, 9:56 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
2021-12-01
|
Recruitment status
Last imported at : March 1, 2023, 9:56 a.m.
Source : ClinicalTrials.gov
|
Terminated
|
Study design
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
positive sars-cov-2 rna pcr swab
inflamatory phase of infection
hfno
|
Exclusion criteria
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
pregnancy
previous treatment with dnase alfa
|
Number of arms
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
University Medical Centre Ljubljana
|
Inclusion age min
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : March 1, 2023, 9:56 a.m.
Source : ClinicalTrials.gov
|
Slovenia
|
Type of patients
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
Severe disease at enrollment
|
Severity scale
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
6: Severe disease at enrollment
|
Total sample size
Last imported at : March 1, 2023, 9:56 a.m.
Source : ClinicalTrials.gov
|
10
|
primary outcome
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
Intubations
|
Notes
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Dec. 2, 2021, 11:30 p.m.
Source : ClinicalTrials.gov
|
Phase 4
|
Arms
Last imported at : Dec. 19, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 416, "treatment_name": "Dornase alfa", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|